Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains Market Perform Rating and Raises Price Target for SmartFinancial

Elaine Mendonca by Elaine Mendonca
January 24, 2024
in Breaking News
0
Finance_Financialization
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

On January 24, 2024, Catherine Mealor, an analyst at Keefe, Bruyette & Woods, expressed her confidence in SmartFinancial (NASDAQ:SMBK) by maintaining a Market Perform rating. Notably, Mealor also increased the price target for the company’s stock from $25 to $26. This adjustment implies that SmartFinancial is anticipated to exhibit a performance that aligns with the overall market. Moreover, the raised price target signifies an optimistic outlook for the company’s stock.

SMBK Stock Shows Positive Performance and Promising Outlook for Investors in 2024

On January 24, 2024, SMBK stock exhibited a positive performance, with a price increase of $0.42 or 1.79%. The stock closed at $23.90, indicating a favorable outcome for investors. SMBK is currently trading in the middle of its 52-week range, suggesting stability and potential for further growth or decline. Additionally, SMBK is trading above its 200-day moving average, indicating a positive long-term trend. The stock remained unchanged in after-hours trading, suggesting no significant market reaction or news affecting its price. Overall, these indicators point to a promising outlook for SMBK stock.

SMBK Stock Performance on January 24, 2024: Strong Revenue Growth and Resilience in Net Income

SMBK Stock Performance on January 24, 2024: A Steady Growth Amidst Mixed Results

Introduction:
On January 24, 2024, SMBK stock showcased a commendable performance, reflecting the company’s ability to navigate through challenging economic conditions.

Total Revenue:
SMBK reported total revenue of $240.37 million over the past year, representing a significant increase of 30.36% compared to the previous year. Moreover, the company’s total revenue increased by 16.96% since the last quarter.

Net Income:
While SMBK’s total revenue experienced substantial growth, the net income figures present a mixed picture. The company reported a net income of $28.59 million over the past year, reflecting a decline of 33.54% compared to the previous year. However, the net income surged by an impressive 199.47% since the last quarter, showcasing a remarkable recovery and highlighting the company’s resilience.

Earnings per Share:
SMBK’s earnings per share (EPS) is a crucial metric that provides insights into the company’s profitability on a per-share basis. Over the past year, the company reported an EPS of $1.69, marking a decline of 33.73% compared to the previous year. However, it is worth noting that the EPS remained flat since the last quarter, indicating stability and potential for future growth.

Conclusion:
Despite facing challenges in terms of net income and earnings per share, SMBK stock showcased a commendable performance on January 24, 2024. The company’s total revenue witnessed significant growth, indicating its ability to expand its market presence and generate higher sales. Additionally, the substantial increase in net income since the last quarter highlights the company’s resilience and potential for recovery. While the decline in net income and earnings per share over the past year raises concerns, the stability observed in the last quarter suggests that SMBK is on the path to regaining profitability. As always, investors should conduct further research and analysis to make informed decisions regarding SMBK stock.

Tags: SMBK
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Food Producers Stock Bull Market

Analyzing Rithm Capital Incs Market Performance Through the PE Ratio

FDA Issues Black Box Warning for CART Therapies Due to Risk of Secondary TCell Cancers

Finance_Investment (2)

Analyst Upgrades Synchrony Financials Price Target Amid Positive Outlook

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com